The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects
NCT01921647 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2013-12-03
Summary
The objective of this study is not only to explore pharmacokinetic interaction after single oral administration but also pharmacodynamics interaction after multiple oral administration of YH4808, amoxicillin and clarithromycin each separately versus coadministration of YH4808, amoxicillin and clarithromycin in healthy volunteers
Conditions
- Healthy
Interventions
- DRUG
-
YH4808
- DRUG
-
Nexium
- DRUG
-
Amoxicillin
- DRUG
-
clarithromycin
Sponsors & Collaborators
-
Yuhan Corporation
lead INDUSTRY
Principal Investigators
-
Min soo Park, Ph.D, M.D. · Severance Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
NCT05742568 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
NCT03487562 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth
NCT04444011 ·Status: UNKNOWN ·Phase: PHASE1
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA
-
Tailored H. Pylori Eradication Based on Clarithromycin Resistance
NCT03884348 ·Status: COMPLETED
-
The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.
NCT03583476 ·Status: UNKNOWN
-
Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection
NCT05419674 ·Status: UNKNOWN ·Phase: PHASE4
-
TAK-438 Bismuth Drug Interaction Study
NCT02892409 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy
NCT02646332 ·Status: COMPLETED ·Phase: NA
-
Helicobacter Pylori Eradication Study
NCT03130452 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT04558502 ·Status: UNKNOWN ·Phase: PHASE4
-
Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication
NCT02175901 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients
NCT03099876 ·Status: UNKNOWN
-
Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients
NCT05023577 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication
NCT07333001 ·Status: COMPLETED
-
The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
NCT02648659 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
NCT03317223 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection
NCT06250634 ·Status: COMPLETED ·Phase: NA
-
Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy
NCT01607918 ·Status: UNKNOWN ·Phase: PHASE4
-
Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy
NCT05237115 ·Status: COMPLETED ·Phase: PHASE4
-
Tailored Therapy for Clarithromycin-Resistant H. Pylori
NCT03431688 ·Status: COMPLETED ·Phase: NA
-
A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804
NCT01589614 ·Status: COMPLETED ·Phase: PHASE1
-
Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
NCT02401477 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Vonoprazan in Adults With Helicobacter Pylori
NCT04753437 ·Status: COMPLETED ·Phase: PHASE1
-
Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection
NCT01481844 ·Status: COMPLETED ·Phase: PHASE3